Brain cancer drugs approved in England

England's National Institute for Health and Clinical Excellence has removed a ban on two drugs that may help patients with rare life-threatening brain cancer.

Temodal and Gliadel may now be obtained through the National Health Service. The 2005 ban was based on cost-effectiveness.

The Times of London says the ban caused anger because Temodal was actually invented by British scientists with funding from Cancer Research UK.

Gliadel is a wafer that, when placed at the site where a brain tumor was removed, clears remaining cancer cells and keeps the tumor from recurring, the newspaper said.

Both drugs have been available in the United States and Canada.

Ella Pybus, spokeswoman for a consortium of cancer charities, said, "Everyone is relieved."

She said there is "solid evidence" the drugs help patients.

Copyright 2007 by United Press International


Explore further

What is fentanyl? 10 things to know about the potentially deadly drug

Citation: Brain cancer drugs approved in England (2007, April 11) retrieved 25 May 2019 from https://medicalxpress.com/news/2007-04-brain-cancer-drugs-england.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more